Primary drug resistance among tuberculosis patients with diabetes mellitus: a retrospective study among 7223 cases in China

References

• World Health Organization. Global tuberculosis report 2018; 2018 [cited 1211, 2018]. Available from: https://www.who.int/tb/publications/global_report. Accessed 719, 2017
   Google Scholar
• World health statistics 2018. Available from: http://apps.who.int/iris/bitstream/handle/10665/272596/9789241565585-eng.pdf?ua=1. Accessed 719, 2017
   Google Scholar
• Restrepo BI. Diabetes and Tuberculosis[M]//Understanding the Host Immune Response against Mycobacterium Tuberculosis Infection. Cham: Springer; 2018:1–21.
   Google Scholar
• Ugarte-Gil C, Alisjahbana B, Ronacher K, et al. Diabetes mellitus among pulmonary tuberculosis patients from four TB-endemic countries: the TANDEM study. Clin Infect Dis. 2019. doi:10.1093/cid/ciz284
   Web of Science ®Google Scholar
• Golub JE, Mok Y, Hong S, et al. Diabetes mellitus and tuberculosis in Korean adults: impact on tuberculosis incidence, recurrence and mortality. Int J Tuberc Lung Dis. 2019;23(4):507–513. doi:10.5588/ijtld.18.010331064631
   PubMed Web of Science ®Google Scholar
• Critchley JA, Restrepo BI, Ronacher K, et al. Defining a research agenda to address the converging epidemics of tuberculosis and diabetes: part 1: epidemiology and clinical management. Chest. 2017;152(1):165–173. doi:10.1016/j.chest.2017.04.15528434936
   PubMed Web of Science ®Google Scholar
• Gandhi NR, Nunn P, Dheda K, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375(9728):1830–1843. doi:10.1016/S0140-6736(10)60410-220488523
   PubMed Web of Science ®Google Scholar
• Yang C, Luo T, Shen X, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigation. Lancet Infect Dis. 2017;17(3):275–284. doi:10.1016/S1473-3099(16)30418-227919643
   PubMed Web of Science ®Google Scholar
• Magee MJ, Bloss E, Shin SS, et al. Clinical characteristics, drug resistance, and treatment outcomes among tuberculosis patients with diabetes in Peru. Int J Infect Dis. 2013;17(6):e404–e412. doi:10.1016/j.ijid.2012.12.02923434400
   PubMed Web of Science ®Google Scholar
• Perez-Navarro LM, Restrepo BI, Fuentes-Dominguez FJ, et al. The effect size of type 2 diabetes mellitus on tuberculosis drug resistance and adverse treatment outcomes. Tuberculosis. 2017;103:83–91. doi:10.1016/j.tube.2017.01.00628237037
   PubMed Web of Science ®Google Scholar
• Liu Q, Li W, Xue M, et al. Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis. Sci Rep. 2017;7(1):1090. doi:10.1038/s41598-017-01213-528439071
   PubMed Web of Science ®Google Scholar
• Wang L, Zhang H, Ruan Y, et al. Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data. Lancet. 2014;383(9934):2057–2064. doi:10.1016/S0140-6736(13)62639-224650955
   PubMed Web of Science ®Google Scholar
• Yang F, Qian D, Chen J, et al. Prevalence, awareness, treatment and control of diabetes mellitus in rural China: results from Shandong Province. Diabetic Med. 2016;33(4):454–458. doi:10.1111/dme.1284226108553
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhao B, Xu S, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012;366(23):2161–2170. doi:10.1056/NEJMoa110878922670902
   PubMed Web of Science ®Google Scholar
• El Amin NM, Hanson HS, Pettersson B, Petrini B, Von Stedingk LV. Identification of non-tuberculous mycobacteria: 16S rRNA gene sequenceanalysis vs. conventional methods. Scand J Infect Dis. 2000;32:47–50.10716077
   PubMedGoogle Scholar
• Jing H, Wang H, Wang Y, et al. Prevalence of nontuberculous mycobacteria infection, China, 2004–2009. Emerg Infect Dis. 2012;18(3):527–528. doi:10.3201/eid1803.11017522376989
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(Supplement 1):S62–S69. doi:10.2337/dc10-S06220042775
   PubMed Web of Science ®Google Scholar
• Type 2 diabetes ADA diagnosis criteria-medscape (eMedicine), Available from: https://emedicine.medscape.com/article/2172154-overview. Accessed 719, 2017
   Google Scholar
• Van Rie A, Warren R, Richardson M, et al. Classification of drug-resistant tuberculosis in an epidemic area. Lancet. 2000;356(9223):22–25. doi:10.1016/S0140-6736(00)02429-610892760
   PubMed Web of Science ®Google Scholar
• Falzon D, Schünemann HJ, Harausz E, et al. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update. Eur Respir J. 2017;49(3):1602308. doi:10.1183/13993003.02308-201628331043
   PubMed Web of Science ®Google Scholar
• McMurry HS, Mendenhall E, Rajendrakumar A, et al. Coprevalence of type 2 diabetes mellitus and tuberculosis in low‐income and middle‐income countries: a systematic review. Diabetes Metab Res Rev. 2019;35(1):e3066. doi:10.1002/dmrr.306630144270
   PubMed Web of Science ®Google Scholar
• Kumar Nathella P, Babu S. Influence of diabetes mellitus on immunity to human tuberculosis. Immunology. 2017;152(1):13–24. doi:10.1111/imm.1276228543817
   PubMed Web of Science ®Google Scholar
• Lachmandas E, Van Den Heuvel CN, Damen AM, et al. Diabetes mellitus and increased tuberculosis susceptibility: the role of short-chain fatty acids. J Diabetes Res. 2016;2016: 6014631–15. doi:10.1155/2016/6014631
   Web of Science ®Google Scholar
• Dobler CC, Flack JR, Marks GB. Risk of tuberculosis among people with diabetes mellitus: an Australian nationwide cohort study. BMJ Open. 2012;2(1):e000666. doi:10.1136/bmjopen-2011-000666
   PubMed Web of Science ®Google Scholar
• S C P, C C K, Kao D, et al. Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling study. Lancet Diabetes Endocrinol. 2015;3(5):323–330. doi:10.1016/S2213-8587(15)00042-X25754415
   PubMed Web of Science ®Google Scholar
• Wu Z, Guo J, Huang Y, et al. Diabetes mellitus in patients with pulmonary tuberculosis in an aging population in Shanghai, China: prevalence, clinical characteristics and outcomes. J Diabetes Complications. 2016;30(2):237–241. doi:10.1016/j.jdiacomp.2015.11.01426684166
   PubMed Web of Science ®Google Scholar
• Abdullah A, Peeters A, de Courten M, Stoelwinder J. The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Diabetes Res Clin Pract. 2010;89(3):309–319. doi:10.1016/j.diabres.2010.04.01220493574
   PubMed Web of Science ®Google Scholar
• Faurholt-Jepsen D, Range N, PrayGod G, et al. The role of anthropometric and other predictors for diabetes among urban Tanzanians with tuberculosis. Int J Tuberc Lung Dis. 2012;16(12):1680–1685. doi:10.5588/ijtld.12.036023131269
   PubMed Web of Science ®Google Scholar
• Magee MJ, Kempker RR, Kipiani M, et al. Diabetes mellitus is associated with cavities, smear grade, and multidrug-resistant tuberculosis in Georgia. Int J Tuberc Lung Dis. 2015;19(6):685–692. doi:10.5588/ijtld.14.081125946360
   PubMed Web of Science ®Google Scholar
• W B L, Zhang YQ, Xing J, et al. Factors associated with primary transmission of multidrug-resistant tuberculosis compared with healthy controls in Henan Province, China. Infect Dis Poverty. 2015;4(1):14. doi:10.1186/s40249-015-0045-125806104
   PubMed Web of Science ®Google Scholar
• Gagneux S. Fitness cost of drug resistance in Mycobacterium tuberculosis. Clin Microbiol Infect. 2009;15:66–68. doi:10.1111/j.1469-0691.2008.02685.x
   Web of Science ®Google Scholar
• Grandjean L, Gilman RH, Martin L, et al. Transmission of multidrug-resistant and drug-susceptible tuberculosis within households: a prospective cohort study. PLoS Med. 2015;12(6):e1001843. doi:10.1371/journal.pmed.100180926103620
   PubMed Web of Science ®Google Scholar
• Fisher-Hoch SP, Whitney E, McCormick JB, et al. Type 2 diabetes and multidrug-resistant tuberculosis. Scand J Infect Dis. 2008;40(11–12):888–893. doi:10.1080/0036554080234237218728934
   PubMed Web of Science ®Google Scholar
• Gagneux S, Burgos MV, DeRiemer K, et al. Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. PLoS Pathog. 2006;2(6):e61. doi:10.1371/journal.ppat.002006116789833
   PubMed Web of Science ®Google Scholar
• Mitchison DA. Tubercle bacilli resistant to isoniazid; virulence and response to treatment with isoniazid in guinea-pigs. BMJ. 1954;1:128–130. doi:10.1136/bmj.1.4854.12813106496
   PubMed Web of Science ®Google Scholar
• Middlebrook G, Cohn ML. Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli. Science. 1953;118:297–299. doi:10.1126/science.118.3063.29713089681
   PubMed Web of Science ®Google Scholar
• Van Soolingen D, Borgdorff MW, de Haas PE, et al. Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997. J Infect Dis. 1999;180:726–736. doi:10.1086/31493010438361
   PubMed Web of Science ®Google Scholar
• Carey IM, Critchley JA, DeWilde S, et al. Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study. Diabetes Care. 2018;41(3):513–521. doi:10.2337/dc17-213129330152
   PubMed Web of Science ®Google Scholar